Dr. Robert G. Hale, a leading oral and maxillofacial surgeon, announced the launch of the first FDA-approved device, the KLS Martin Preprosthetic, specifically designed for patients who are not suitable candidates for traditional implants.
The system offers a predictable and durable solution for patients with underdeveloped alveolar ridges or previous implant failures.
Previously, many patients with insufficient maxillary bone or implant complications were left with invasive treatments such as extensive bone grafting, sinus lifts, or zygomatic implants. The KLS Martin Preprosthetic offers a breakthrough alternative.
The minimally invasive procedure, performed under sedation and taking approximately 90 minutes, allows patients who were previously told they could not recover to regain chewing function, comfort, and quality of life.
“This is a completely new solution for patients who were once told they could not have dental implants,” said Dr. Hale. “With the KLS Martin Preprosthetic, we can provide a more predictable and efficient restoration even when traditional methods have failed.”
As an early clinical investigator for this device, Dr. Hale is dedicated not only to patient care but also to advancing the industry as a whole. He is collaborating with KLS Martin to train dental professionals nationwide in this next-generation implant technology.
KLS Martin Preprosthetics promises to reshape implant dentistry by reducing complications, shortening treatment times, and providing an FDA-approved alternative when traditional implants are not feasible. Dr. Hale is highly regarded for his pioneering work in advanced implant solutions.
In addition to his extensive clinical experience, he served as a colonel in the U.S. Army Dental Corps and conducted maxillofacial reconstruction research at top military medical centers. By collaborating with leading medical device manufacturers, Dr. Hale is committed to bringing patients evidence-based, innovative, and comfortable treatment options.
